» Articles » PMID: 27223822

Systems Metabolic Engineering of Escherichia Coli

Overview
Journal EcoSal Plus
Specialty Microbiology
Date 2016 May 26
PMID 27223822
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Systems metabolic engineering, which recently emerged as metabolic engineering integrated with systems biology, synthetic biology, and evolutionary engineering, allows engineering of microorganisms on a systemic level for the production of valuable chemicals far beyond its native capabilities. Here, we review the strategies for systems metabolic engineering and particularly its applications in Escherichia coli. First, we cover the various tools developed for genetic manipulation in E. coli to increase the production titers of desired chemicals. Next, we detail the strategies for systems metabolic engineering in E. coli, covering the engineering of the native metabolism, the expansion of metabolism with synthetic pathways, and the process engineering aspects undertaken to achieve higher production titers of desired chemicals. Finally, we examine a couple of notable products as case studies produced in E. coli strains developed by systems metabolic engineering. The large portfolio of chemical products successfully produced by engineered E. coli listed here demonstrates the sheer capacity of what can be envisioned and achieved with respect to microbial production of chemicals. Systems metabolic engineering is no longer in its infancy; it is now widely employed and is also positioned to further embrace next-generation interdisciplinary principles and innovation for its upgrade. Systems metabolic engineering will play increasingly important roles in developing industrial strains including E. coli that are capable of efficiently producing natural and nonnatural chemicals and materials from renewable nonfood biomass.

Citing Articles

Optimizing strains and fermentation processes for enhanced L-lysine production: a review.

Wu Z, Chen T, Sun W, Chen Y, Ying H Front Microbiol. 2024; 15:1485624.

PMID: 39430105 PMC: 11486702. DOI: 10.3389/fmicb.2024.1485624.


Harnessing synthetic biology for advancing RNA therapeutics and vaccine design.

Pfeifer B, Beitelshees M, Hill A, Bassett J, Jones C NPJ Syst Biol Appl. 2023; 9(1):60.

PMID: 38036580 PMC: 10689799. DOI: 10.1038/s41540-023-00323-3.


Application of different types of CRISPR/Cas-based systems in bacteria.

Liu Z, Dong H, Cui Y, Cong L, Zhang D Microb Cell Fact. 2020; 19(1):172.

PMID: 32883277 PMC: 7470686. DOI: 10.1186/s12934-020-01431-z.


Engineering Clostridial Aldehyde/Alcohol Dehydrogenase for Selective Butanol Production.

Cho C, Hong S, Moon H, Jang Y, Kim D, Lee S mBio. 2019; 10(1).

PMID: 30670620 PMC: 6343042. DOI: 10.1128/mBio.02683-18.


Boosting Secondary Metabolite Production and Discovery through the Engineering of Novel Microbial Biosensors.

de Frias U, Pereira G, Guazzaroni M, Silva-Rocha R Biomed Res Int. 2018; 2018:7021826.

PMID: 30079350 PMC: 6069586. DOI: 10.1155/2018/7021826.


References
1.
Lehnherr H, Maguin E, Jafri S, Yarmolinsky M . Plasmid addiction genes of bacteriophage P1: doc, which causes cell death on curing of prophage, and phd, which prevents host death when prophage is retained. J Mol Biol. 1993; 233(3):414-28. DOI: 10.1006/jmbi.1993.1521. View

2.
Chung H, Kim T, Lee S . Recent advances in production of recombinant spider silk proteins. Curr Opin Biotechnol. 2012; 23(6):957-64. DOI: 10.1016/j.copbio.2012.03.013. View

3.
Vinuselvi P, Kuk Lee S . Engineered Escherichia coli capable of co-utilization of cellobiose and xylose. Enzyme Microb Technol. 2011; 50(1):1-4. DOI: 10.1016/j.enzmictec.2011.10.001. View

4.
Kerfeld C, Heinhorst S, Cannon G . Bacterial microcompartments. Annu Rev Microbiol. 2010; 64:391-408. DOI: 10.1146/annurev.micro.112408.134211. View

5.
Urban J, Vogel J . Two seemingly homologous noncoding RNAs act hierarchically to activate glmS mRNA translation. PLoS Biol. 2008; 6(3):e64. PMC: 2267818. DOI: 10.1371/journal.pbio.0060064. View